The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
The global Darunavir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Darunavir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Darunavir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Darunavir in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Darunavir include Janssen Therapeutics, Mylan, Teva, Cipla, Lupin and Hetero, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Darunavir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Darunavir.
Report Scope
The Darunavir market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Darunavir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Darunavir companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Janssen Therapeutics
Mylan
Teva
Cipla
Lupin
Hetero
Segment by Type
Tablet
Oral suspension
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Darunavir companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Darunavir (DRV), sold under the brand name Prezista among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
The global Darunavir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Darunavir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Darunavir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Darunavir in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Darunavir include Janssen Therapeutics, Mylan, Teva, Cipla, Lupin and Hetero, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Darunavir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Darunavir.
Report Scope
The Darunavir market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Darunavir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Darunavir companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Janssen Therapeutics
Mylan
Teva
Cipla
Lupin
Hetero
Segment by Type
Tablet
Oral suspension
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Darunavir companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Darunavir Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablet
1.2.3 Oral suspension
1.3 Market by Application
1.3.1 Global Darunavir Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Darunavir Market Perspective (2019-2030)
2.2 Darunavir Growth Trends by Region
2.2.1 Global Darunavir Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Darunavir Historic Market Size by Region (2019-2024)
2.2.3 Darunavir Forecasted Market Size by Region (2025-2030)
2.3 Darunavir Market Dynamics
2.3.1 Darunavir Industry Trends
2.3.2 Darunavir Market Drivers
2.3.3 Darunavir Market Challenges
2.3.4 Darunavir Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Darunavir Players by Revenue
3.1.1 Global Top Darunavir Players by Revenue (2019-2024)
3.1.2 Global Darunavir Revenue Market Share by Players (2019-2024)
3.2 Global Darunavir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Darunavir Revenue
3.4 Global Darunavir Market Concentration Ratio
3.4.1 Global Darunavir Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Darunavir Revenue in 2023
3.5 Darunavir Key Players Head office and Area Served
3.6 Key Players Darunavir Product Solution and Service
3.7 Date of Enter into Darunavir Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Darunavir Breakdown Data by Type
4.1 Global Darunavir Historic Market Size by Type (2019-2024)
4.2 Global Darunavir Forecasted Market Size by Type (2025-2030)
5 Darunavir Breakdown Data by Application
5.1 Global Darunavir Historic Market Size by Application (2019-2024)
5.2 Global Darunavir Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Darunavir Market Size (2019-2030)
6.2 North America Darunavir Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Darunavir Market Size by Country (2019-2024)
6.4 North America Darunavir Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Darunavir Market Size (2019-2030)
7.2 Europe Darunavir Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Darunavir Market Size by Country (2019-2024)
7.4 Europe Darunavir Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Darunavir Market Size (2019-2030)
8.2 Asia-Pacific Darunavir Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Darunavir Market Size by Region (2019-2024)
8.4 Asia-Pacific Darunavir Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Darunavir Market Size (2019-2030)
9.2 Latin America Darunavir Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Darunavir Market Size by Country (2019-2024)
9.4 Latin America Darunavir Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Darunavir Market Size (2019-2030)
10.2 Middle East & Africa Darunavir Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Darunavir Market Size by Country (2019-2024)
10.4 Middle East & Africa Darunavir Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Janssen Therapeutics
11.1.1 Janssen Therapeutics Company Detail
11.1.2 Janssen Therapeutics Business Overview
11.1.3 Janssen Therapeutics Darunavir Introduction
11.1.4 Janssen Therapeutics Revenue in Darunavir Business (2019-2024)
11.1.5 Janssen Therapeutics Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Darunavir Introduction
11.2.4 Mylan Revenue in Darunavir Business (2019-2024)
11.2.5 Mylan Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Darunavir Introduction
11.3.4 Teva Revenue in Darunavir Business (2019-2024)
11.3.5 Teva Recent Development
11.4 Cipla
11.4.1 Cipla Company Detail
11.4.2 Cipla Business Overview
11.4.3 Cipla Darunavir Introduction
11.4.4 Cipla Revenue in Darunavir Business (2019-2024)
11.4.5 Cipla Recent Development
11.5 Lupin
11.5.1 Lupin Company Detail
11.5.2 Lupin Business Overview
11.5.3 Lupin Darunavir Introduction
11.5.4 Lupin Revenue in Darunavir Business (2019-2024)
11.5.5 Lupin Recent Development
11.6 Hetero
11.6.1 Hetero Company Detail
11.6.2 Hetero Business Overview
11.6.3 Hetero Darunavir Introduction
11.6.4 Hetero Revenue in Darunavir Business (2019-2024)
11.6.5 Hetero Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Darunavir Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tablet
Table 3. Key Players of Oral suspension
Table 4. Global Darunavir Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Darunavir Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Darunavir Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Darunavir Market Share by Region (2019-2024)
Table 8. Global Darunavir Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Darunavir Market Share by Region (2025-2030)
Table 10. Darunavir Market Trends
Table 11. Darunavir Market Drivers
Table 12. Darunavir Market Challenges
Table 13. Darunavir Market Restraints
Table 14. Global Darunavir Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Darunavir Market Share by Players (2019-2024)
Table 16. Global Top Darunavir Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Darunavir as of 2023)
Table 17. Ranking of Global Top Darunavir Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Darunavir Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Darunavir Product Solution and Service
Table 21. Date of Enter into Darunavir Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Darunavir Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Darunavir Revenue Market Share by Type (2019-2024)
Table 25. Global Darunavir Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Darunavir Revenue Market Share by Type (2025-2030)
Table 27. Global Darunavir Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Darunavir Revenue Market Share by Application (2019-2024)
Table 29. Global Darunavir Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Darunavir Revenue Market Share by Application (2025-2030)
Table 31. North America Darunavir Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Darunavir Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Darunavir Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Darunavir Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Darunavir Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Darunavir Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Darunavir Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Darunavir Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Darunavir Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Darunavir Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Darunavir Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Darunavir Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Darunavir Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Darunavir Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Darunavir Market Size by Country (2025-2030) & (US$ Million)
Table 46. Janssen Therapeutics Company Detail
Table 47. Janssen Therapeutics Business Overview
Table 48. Janssen Therapeutics Darunavir Product
Table 49. Janssen Therapeutics Revenue in Darunavir Business (2019-2024) & (US$ Million)
Table 50. Janssen Therapeutics Recent Development
Table 51. Mylan Company Detail
Table 52. Mylan Business Overview
Table 53. Mylan Darunavir Product
Table 54. Mylan Revenue in Darunavir Business (2019-2024) & (US$ Million)
Table 55. Mylan Recent Development
Table 56. Teva Company Detail
Table 57. Teva Business Overview
Table 58. Teva Darunavir Product
Table 59. Teva Revenue in Darunavir Business (2019-2024) & (US$ Million)
Table 60. Teva Recent Development
Table 61. Cipla Company Detail
Table 62. Cipla Business Overview
Table 63. Cipla Darunavir Product
Table 64. Cipla Revenue in Darunavir Business (2019-2024) & (US$ Million)
Table 65. Cipla Recent Development
Table 66. Lupin Company Detail
Table 67. Lupin Business Overview
Table 68. Lupin Darunavir Product
Table 69. Lupin Revenue in Darunavir Business (2019-2024) & (US$ Million)
Table 70. Lupin Recent Development
Table 71. Hetero Company Detail
Table 72. Hetero Business Overview
Table 73. Hetero Darunavir Product
Table 74. Hetero Revenue in Darunavir Business (2019-2024) & (US$ Million)
Table 75. Hetero Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Darunavir Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Darunavir Market Share by Type: 2023 VS 2030
Figure 3. Tablet Features
Figure 4. Oral suspension Features
Figure 5. Global Darunavir Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Darunavir Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Drug store Case Studies
Figure 9. Darunavir Report Years Considered
Figure 10. Global Darunavir Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Darunavir Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Darunavir Market Share by Region: 2023 VS 2030
Figure 13. Global Darunavir Market Share by Players in 2023
Figure 14. Global Top Darunavir Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Darunavir as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Darunavir Revenue in 2023
Figure 16. North America Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Darunavir Market Share by Country (2019-2030)
Figure 18. United States Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Darunavir Market Share by Country (2019-2030)
Figure 22. Germany Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Darunavir Market Share by Region (2019-2030)
Figure 30. China Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Darunavir Market Share by Country (2019-2030)
Figure 38. Mexico Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Darunavir Market Share by Country (2019-2030)
Figure 42. Turkey Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Darunavir Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Janssen Therapeutics Revenue Growth Rate in Darunavir Business (2019-2024)
Figure 45. Mylan Revenue Growth Rate in Darunavir Business (2019-2024)
Figure 46. Teva Revenue Growth Rate in Darunavir Business (2019-2024)
Figure 47. Cipla Revenue Growth Rate in Darunavir Business (2019-2024)
Figure 48. Lupin Revenue Growth Rate in Darunavir Business (2019-2024)
Figure 49. Hetero Revenue Growth Rate in Darunavir Business (2019-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
